Simultaneous Administration of Insulin‐Like Growth Factor‐1 and Darbepoetin Alfa Protects the Rat Myocardium Against Myocardial Infarction and Enhances Angiogenesis

Recent studies have shown that insulin growth factor‐1 (IGF‐1) and either erythropoietin (EPO) or the long‐acting EPO analog Darbepoetin alfa (DA) protect the heart against ischemia/reperfusion (I/R) and myocardial infarction (MI). The present study examined the cardioprotective effect of simultaneo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Boucher, Matthieu, Pesant, Stéphanie, Lei, Yong Hong, Nanton, Natasha, Most, Patrick, Eckhart, Andrea D., Koch, Walter J., Gao, Erhe
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Inc 2008
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3016870/
https://ncbi.nlm.nih.gov/pubmed/20443814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1752-8062.2008.00008.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars